• Policy
• 2 indications deleted for choline alfoscerate, changes label
• by Lee, Tak-Sun Jun 30, 2021 05:56am

• Opinion
• [Reporter’s view] Confusion by 1+3 bill must be minimized
• by Lee, Tak-Sun Jun 30, 2021 05:56am

• Company
• JW Pharma acquires domestic license for fostamatinib
• by Chon, Seung-Hyun Jun 30, 2021 05:56am

• Policy
• Will Rosuvastatin OD be released?
• by Lee, Tak-Sun Jun 30, 2021 05:55am

• Company
• Amitiza can be prescribed at general hospitals
• by Eo, Yun-Ho Jun 29, 2021 05:46am

• Company
• Select the right initial treatment for kidney cancer
• by Jun 29, 2021 05:46am

• Policy
• Janssen Vaccine for 10,800 people has been approved
• by Lee, Tak-Sun Jun 29, 2021 05:46am

• Policy
• Leclaza was listed at ₩68,964 per tablet
• by Kim, Jung-Ju Jun 29, 2021 05:46am

• Company
• Attention focused on children’s NIP flu vaccine supply
• by Whang, byung-woo Jun 29, 2021 05:46am

• Policy
• Following Gilead's hepatitis C tx Epclusa, Vosevi was filed
• by Lee, Tak-Sun Jun 28, 2021 05:50am